Due to the rapid onset of action of the product, the risk of transmission of diseases by parasites is significantly reduced
Product safety was demonstrated in pregnant and breastfeeding treated with an overdose of up to 3 times the maximum recommended dose.
The product's safety was demonstrated in puppies aged 8-9 weeks and 2-3.6 kg of weight treated with an overdose of up to 5 times the maximum recommended dose on 3 occasions at intervals less (8 weeks) than indicated.
The product was well tolerated in Collies dogs with multiple drug resistance protein deficiency 1 (MDR1 - / -) following a single administration of 3 times the indicated dose.
For optimal flea and tick control, the product should be administered at intervals of 12 weeks. Bravecto can be helped throughout the year.
Skip to content
